What is ACB stock price today?

ACB (Aurora Cannabis Inc) stock is trading at $4.14 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is ACB stock going up or down today?

ACB stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy ACB stock now?

The decision to buy ACB depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is ACB a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for ACB based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is ACB stock overvalued or undervalued?

Use our DCF valuation calculator to determine if ACB is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is ACB's P/E ratio?

P/E ratio data for ACB will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is ACB's market cap?

ACB (Aurora Cannabis Inc) has a market capitalization of $0.24 billion, making it a small-cap stock.

What is ACB's price to book ratio?

ACB trades at a price-to-book (P/B) ratio of 0.62, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does ACB pay dividends?

ACB does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is ACB's dividend yield?

ACB does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is ACB stock a good long-term investment?

ACB's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is ACB's revenue growth rate?

ACB has shown revenue growth of 0.1% over recent periods. Consistent revenue growth is a key indicator of business health and competitive positioning.

ACB is currently operating at a loss. Some companies prioritize growth over profitability in early stages. Review our financial analysis for detailed insights.

What are the risks of investing in ACB?

Key risks for ACB include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does ACB compare to its competitors?

Compare ACB to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize ACB's performance and positioning.

What is ACB's stock price target for 2026?

Our AI model provides price targets for ACB based on fundamental analysis: Bull case $5.38 (+30%), Base case $4.76 (+15%), Bear case $3.73 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about ACB?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for ACB. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is ACB's next earnings report?

ACB reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

ACB - Aurora Cannabis Inc

NYSE * Health Care * Pharmaceuticals

$4.14

$-0.09 (-2.13%)

About Aurora Cannabis Inc

Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. It operates through two segments, Canadian Cannabis and Plant Propagation. The company offers pharmaceutical-grade cannabis products; medical and consumer cannabis products; and engages in the propagation of vegetables and floral plants. It also provides dried and fresh cannabis, cannabis oils, trims, concentrates, ingestibles, capsules, vaporizers, edible cannabis, cannabis extracts, and cannabis topicals; and patient counseling and outreach services. Its brand portfolio includes San Rafael '71, Greybeard, Drift, Daily Special, Being, CanniMed, MedReleaf, Aurora, and WMMC, as well as international brands include Pedanios, Bidiol, IndiMed, and CraftPlant. The company was founded in 2013 and is headquartered in Edmonton, Canada.

ACB Key Statistics

Market Cap

$239.31M

P/B Ratio

0.62

EPS

$-0.73

Revenue Growth

+0.1%

Profit Margin

-0.2%

Employees

1,101

How ACB Compares to Peers

ACB is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

of 6

Growth Rank

of 6

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
ACB(This stock)	$239.31M	N/A	0%	-0.2%	-
AAPLApple Inc	$3.66T	33.8	6%	0.3%	vs AAPL
MSFTMicrosoft Corp	$3.38T	36.3	15%	0.4%	vs MSFT
GOOGLAlphabet Inc	$3.89T	23.1	14%	0.3%	vs GOOGL
AMZNAmazon Com	$2.56T	33.8	0%	0.1%	vs AMZN
NVDANvidia Corp	$4.33T	46.1	1%	0.5%	vs NVDA

Aurora Cannabis Inc Company Information

Headquarters: Alberta; Canada
Website: www.auroramj.com
Sector: Health Care
Industry: Pharmaceuticals

About Aurora Cannabis Inc

ACB Key Statistics

How ACB Compares to Peers

Aurora Cannabis Inc Company Information

Upcoming Events for ACB